Interview, Fireside Chat
This is why I don't believe in sales quotas | Figma CRO
- Figma plans to increase sales headcount to support strategic customer work rather than prioritizing efficiency, noting the current team of roughly 300 quota carriers is already highly efficient.
- AI usage monetization via credits is scheduled to begin within a few days, while agentic sales technology solutions are being implemented to reduce data entry friction.
- The SMB segment is expected to experience a delay of a couple of months in securing upgrade transactions post-outreach, whereas enterprise reps will be placed in accounts immediately during onboarding before deep product training.
- A new sales playbook is soft-launching this week with a shift to in-person, classroom-style training, though the organization may need external resources to train sales agents on these new systems.
- Performance frameworks are evolving to prioritize behaviors and competencies over specific quota numbers, which are viewed as lagging indicators, despite setting aggressive quotas to attract talent for complex mid-market and enterprise work.
- Pipeline generation will remain the responsibility of Account Executives rather than a traditional SDR model, with SDR roles currently restructured to focus on existing customers and small renewals rather than new business.
- The traditional SDR function is predicted to be obsolete within two years, although verticalization and overlay teams may eventually be required for high-specialization needs.
- Future sales growth will likely occur over the next few years alongside demand for implementation and adoption consulting, with a founder's 200-rep expansion plan expected to yield approximately 20 strong performers.
- Internal challenges include a potential inability to solve knowledge synchronicity across platforms like Slack and CRM in the immediate future, necessitating a future shift toward a singular content communication approach.
- While Figma does not yet have industry-based teams, the organization may increase investment in sales technology and external resources to bridge current expertise gaps regarding AI and sales enablement.
- Sean Bosganian anticipates that AEs currently struggling due to timing or quota difficulty will eventually convert if they demonstrate the right behaviors and competencies.
- Broader market trends suggest the next wave of AI technology will likely deliver significant advances in drug discovery for rare or chronic illnesses, though this is an external observation separate from Figma's internal sales strategy.